Pharmafile Logo
Pharmafocus logo
Advanced Search

Oklahoma lawyers say J&J is kingpin of pharmaceutical cartel

July 16, 2019
Manufacturing and Production J&J, JJ, Oklahoma, opioid crisis, opioids, pharma

Lawyers representing the State of Oklahoma described Johnson & Johnson as the ‘kingpin’ in a ‘pharmaceutical cartel’ as they accused …

News

GSK teams up with Strathclyde and University of Nottingham

July 16, 2019
Manufacturing and Production GSK, GlaxoSmithKline, UK, britain, pharma, universities

GlaxoSmithKline has teamed up with the University of Nottingham and the University of Strathclyde for a five-year partnership aimed at …

News
boehringer_biberach_germany_copy

Boehringer buys cancer vaccine company AMAL Therapeutics for €325 million

July 16, 2019
Manufacturing and Production AMAL Therapeutics, Boehringer Ingelheim, Geneva, cancer vaccines, oncology

Boehringer Ingelheim has bought Swiss biotech AMAL Therapeutics, a company focused on cancer immunotherapy and cancer vaccines. AMAL’s lead candidate, …

News
darius_hughes

Darius Hughes, Head of Vaccines Business Unit UK, Pfizer

July 15, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Darius Hughes, Pfizer, Working Life, biotech, pharma, vaccines

“Vaccines provide a unique opportunity to have a positive effect on hundreds of thousands of people” – Darius Hughes, Head …

Feature
ema_logo

FDA and EMA fully implement mutual recognition agreement between US and EU

July 15, 2019
Sales and Marketing EMA, FDA, GMP, Slovakia, mra, mutual recognition, pharma

The FDA has recognised Slovakia’s ability to carry out inspections of manufacturing facilties. The recognition of Slovakia marks the full …

News
astrazeneca_building_white

AstraZeneca’s Farxiga fails to get FDA approval for patients with Type 1 diabetes

July 15, 2019
Sales and Marketing AstraZeneca, EMA, FDA, US, diabetes, farxiga

The FDA had said it will not approve AstraZeneca’s diabetes drug Farxiga for use as a supplement to insulin in …

News
gsk_boronia_australia

GSK’s Zejula meets primary endpoint in Phase 3 trial of patients with ovarian cancer

July 15, 2019
Sales and Marketing

British multinational GlaxoSmithKline has said ovarian cancer drug Zejula (niraparib) met its primary endpoint in a Phase 3 trial. Zejula …

News
gilead-sciences

Gilead invests $5.1 billion into Galapagos NV

July 15, 2019
Sales and Marketing Galapagos, Gilead, biotech, collaboration, deal, drug discovery, pharma

Gilead has entered into a 10 year partnership with Belgo-Dutch biotech Galapagos NV. The collaboration will see Gilead invest $5.1 …

News

Generex Biotechnology acquires Medisource Partners

July 15, 2019
Sales and Marketing Generex, Medisource, medical supplies, medicines, pharma, surgery

Canadian firm Generex Biotechnology has acquired Texas-based medical and surgical products distributor Medisource Partners. Under the terms of the deal …

News
astrazeneca_plaque

AstraZeneca’s Imfinzi gets orphan drug designation from FDA

July 12, 2019
Medical Communications AstraZeneca, Cancer, Imfinzi, lung cancer, pharma

AstraZeneca’s cancer immunotherapy Imfinzi has been granted orphan drug status as a treatment for small cell lung cancer (SCLC). The …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

July 12, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HPV, NHS, NICE, Novartis, Pfizer, Trump, pharma, vaccines

This week’s most popular story covered news of Trump’s claims that he will introduce an executive order to ensure the …

News
bernie_in_phoenix_2015_2

Bernie Sanders to join trip to Canada for cheaper insulin

July 12, 2019
Medical Communications

Senator Bernie Sanders is set to join people with Type 1 diabetes on a trip to Canada in search of …

News
psm_v46_d168_mesial_view_of_the_human_brain

Novartis and Amgen halt trials into Alzheimer’s drug after patients get worse

July 12, 2019
Medical Communications Alzheimer's, Amgen, Banner Alzheimer's Institute, Novartis, dementia, pharma, research

Novartis, Amgen and Banner Alzheimer’s Institute have dropped a study into investigational Alzheimer’s drug CNP520 (umibecestat) after some patient’s conditions …

News

Trump administration drops law to end rebates for PBMs

July 11, 2019
Medical Communications PBMs, Rebates, Trump, USA, pharma, us politics

The Trump administration has dropped plans to introduce a law which would end rebates on prescription drugs under Medicare. The …

News

Scottish NHS patients to access Pfizer’s Ibrance combo in HR+/HER- breast cancer following SMC recommendation

July 11, 2019
Sales and Marketing Cancer, Scotland, Scottish Medicines Consortium, breast cancer, ibrance, pharma

Female NHS patients in Scotland will soon be able to access Pfizer’s cyclin-dependent kinase (CDK) 4/6 inhibitor Ibrance (palbociclib) after …

News
shutterstock_45634132_0

African measles cases surge by 700%

July 11, 2019
Medical Communications, Research and Development Africa, Médecins Sans Frontières, measles, pharma

The number of cases of measles infection on the African continent has surged by 700%, according to data from the …

News
alexa

NHS partners with Amazon to offer health information through Alexa

July 11, 2019
Medical Communications Alexa, NHS, NHS LOng term plan, amazon, digitalisation, pharma, privacy

The NHS is collaborating with e-commerce giant Amazon to provide health information through the voice-activated, ‘virtual assistant’ Alexa. Patients will …

News
neurons-3743011_960_720

Biohaven’s CGPR antagonist migraine treatment beats placebo in Phase 3 trial

July 11, 2019
Research and Development Biohaven, CGPR, clinical trials, headache, migraine, pharma

Connecticut-based firm Biohaven has said its migraine drug rimegepant showed superiority over placebo in a Phase 3 clinical trial. The …

News

Biocon founders donate £6 million to Glasgow University for new research hub

July 10, 2019
Research and Development

The founders of Biocon India have donated £6 million ($7.5 million) to Glasgow University. John Shaw and his wife Kiran …

News
dr_kim_branson

GSK hires computational drug design expert Dr Kim Branson as new head of machine learning and AI

July 10, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

British multinational GlaxoSmithKline have hired computational drug design expert Dr Kim Branson as the company’s new Senior Vice President, Global …

Appointment
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026